InvestorsHub Logo
Followers 21
Posts 3006
Boards Moderated 0
Alias Born 01/27/2022

Re: seve333 post# 423107

Monday, 04/08/2024 4:45:53 PM

Monday, April 08, 2024 4:45:53 PM

Post# of 430137
Seve, I think you can see the case they are building - especially with these most recent developments - for additional approvals in Europe. It's becoming harder and harder for the "non-believers" (see CaptBeer's infamous pic-chart @CaptBeer ) to continue denying the effectiveness of Vascepa.

And I still have a suspicion that something is going to pop in the U.S. I don't know if they are going to use the new formulation to out-maneuver the generics, or if they are confident in litigation. But I feel like something is brewing.

It's tough when they keep everything so close to the vest. But things are starting to stir.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News